Healthcare Equipment and Supplies
Company Overview of NeoVista, Inc.
NeoVista, Inc. develops therapies and medical technologies for the treatment of wet age-related macular degeneration that causes blindness in men and women over the age of 50 years. It develops VIDION ANV Therapy system that is offered as an adjunct therapy to anti-VEGF injections for the treatment of neovascular age-related macular degeneration. NeoVista, Inc. was founded in 2002 and is based in Newark, California.
38875 Cherry Street
Newark, CA 94560
Founded in 2002
Key Executives for NeoVista, Inc.
Similar Private Companies By Industry
|.decimal, Inc.||United States|
|20/20 GeneSystems, Inc.||United States|
|20/20 Imaging LLC||United States|
|21st Century Scientific, Inc.||United States|
|21X Corporation||United States|
Recent Private Companies Transactions
|No transactions available in the past 12 months.|
Most Searched Private Companies
|Company Name||Geographic Region|
|Lawyers Committee for Civil Rights Under Law||United States|
|NYC2012, Inc.||United States|
|Rush University||United States|
|The Advertising Council, Inc.||United States|
Sponsored Financial Commentaries
To contact NeoVista, Inc., please visit --. Company data is provided by Capital IQ. Please use this form to report any data issues.